Cardlytics Total Revenue

The latest total revenue for CDLX is $180M as of June 2026. That compares with $270M in the prior-year period — down 32.6% year over year. That is below the Consumer Discretionary sector average of $1.6T. Investors often review this figure alongside Cardlytics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CDLX's total revenue moved from $270M to $180M — a 32.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cardlytics's operating scale or balance-sheet position.

Against Consumer Discretionary companies, CDLX currently prints $180M for total revenue, while the sector average sits near $1.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Cardlytics's growth, margins, and balance sheet.

A total revenue figure of $180M for CDLX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Consumer Discretionary average is about $1.6T. Explore the charts below for those layers of context.

After noting CDLX's total revenue ($180M), review year-over-year change from $270M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.